Brighter carries out a private placement of SEK 5 million
The Board of Directors of Brighter has, under the authorization from the AGM of 2020, decided on a new share issue of a total of SEK 5 million. Payment will be made in cash. The amount of cash received will be used in full to repay previous loans from these lenders. The reasons for the deviation from the shareholders' preferential rights are to strengthen the company's financial position, which the issue is deemed to entail.
Issue terms:
- 10% discount on the lowest volume-weighted average price of the share during the period on the 15 days, 9th of June to 30th of June. The subscription price is SEK 1.021
- The number of shares in the company increases by 4,897,160, to a total of 352,215,593. The share capital increases by 244,858.00 to a total of SEK 17,610,779.65
For more information, please contact:
Investor Relations
ir@brighter.se
Certified Adviser
Brighter's Certified Adviser is Eminova Fondkommission AB, +46 (0)8 - 684 211 10, adviser@eminova.se, www.eminova.se.
About Brighter AB (publ)
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is a key to providing smarter care for chronic conditions. Our daily-care solutions are designed with a vision to facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – aiming to improve quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter's quality management system is ISO-13485 certified. In 2019 the company won the Swecare Rising Stars Award. The Company's shares are listed on Nasdaq First North Growth Market/BRIG.
For more information, please visit our website at https://brighter.se/